Not available
Quote | ProPhase Labs Inc. (NASDAQ:PRPH)
Last: | $3.24 |
---|---|
Change Percent: | 0.3% |
Open: | $3.27 |
Close: | $3.24 |
High: | $3.4275 |
Low: | $3.24 |
Volume: | 39,009 |
Last Trade Date Time: | 07/17/2024 03:00:00 am |
News | ProPhase Labs Inc. (NASDAQ:PRPH)
2024-07-11 08:46:11 ET More on ProPhase Labs ProPhase Labs: Hidden Gem With An AI Kicker ProPhase Labs, Inc. (PRPH) Q1 2024 Earnings Call Transcript ProPhase Labs Q1 2024 Earnings Preview Seeking Alpha’s Quant Rating on ProPhase Labs Historical...
PMI Revenues and Earnings Projected to Grow Significantly in the Second Half of 2024 and Full Year 2025. New Strategic Initiatives for PMI Create Significant Opportunities for Liquidity and Value Creation Garden City, NY, July 11, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASD...
Message Board Posts | ProPhase Labs Inc. (NASDAQ:PRPH)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $PRPH News Article - ProPhase Labs Announces New $6 Million Stock Repurchase Program | whytestocks | investorshangout | 03/15/2023 1:55:46 PM |
whytestocks: $PRPH News Article - ProPhase Labs Announces Data Presentation for its BE-Smart Esophag | whytestocks | investorshangout | 03/13/2023 3:05:51 PM |
whytestocks: $PRPH News Article - ProPhase Labs' Nebula Genomics Subsidiary Introduces Lowest Ever N | whytestocks | investorshangout | 03/07/2023 6:55:47 PM |
whytestocks: $PRPH News Article - ProPhase Labs to Present at The ThinkEquity Conference | whytestocks | investorshangout | 10/18/2022 5:20:57 PM |
whytestocks: $PRPH News Article - ProPhase Labs to Present at the H.C. Wainwright 24th Annual Global | whytestocks | investorshangout | 09/06/2022 3:40:53 PM |
News, Short Squeeze, Breakout and More Instantly...
PMI Revenues and Earnings Projected to Grow Significantly in the Second Half of 2024 and Full Year 2025. New Strategic Initiatives for PMI Create Significant Opportunities for Liquidity and Value Creation Garden City, NY, July 11, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASD...
Pharmaloz Manufacturing explores strategic alternatives, including potential sale. Company announces major strategic AI initiative, Project ZenQ-AI, leveraging its massive global genomics database and patented discoveries in its BE-Smart Esophageal Cancer Diagnostic Test. BE-Smart...
Pharmaloz Manufacturing explores strategic alternatives, including potential sale. Company announces major strategic AI initiative, Project ZenQ-AI, leveraging its massive global genomics database and patented discoveries in its BE-Smart Esophageal Cancer Diagnostic Test. BE-Sma...